 Sanjana Mehrotra
Concepts (80)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pancreatic Neoplasms | 5 | 2023 | 722 | 1.080 |
Why?
| | Endoscopic Ultrasound-Guided Fine Needle Aspiration | 2 | 2020 | 52 | 0.830 |
Why?
| | Malacoplakia | 1 | 2020 | 1 | 0.720 |
Why?
| | Carcinoma, Neuroendocrine | 1 | 2017 | 29 | 0.570 |
Why?
| | Kidney Neoplasms | 1 | 2020 | 328 | 0.530 |
Why?
| | Neuroendocrine Tumors | 1 | 2017 | 83 | 0.520 |
Why?
| | Histiocytic Sarcoma | 1 | 2015 | 3 | 0.510 |
Why?
| | Cell Transdifferentiation | 1 | 2015 | 31 | 0.500 |
Why?
| | Lymphoma, Follicular | 1 | 2015 | 35 | 0.490 |
Why?
| | Thyroid Neoplasms | 1 | 2017 | 263 | 0.470 |
Why?
| | Biopsy, Fine-Needle | 3 | 2017 | 64 | 0.410 |
Why?
| | Biomarkers, Tumor | 1 | 2015 | 1046 | 0.320 |
Why?
| | In Situ Hybridization, Fluorescence | 2 | 2020 | 310 | 0.280 |
Why?
| | Diagnosis, Differential | 2 | 2020 | 1356 | 0.240 |
Why?
| | Vasculitis | 1 | 2023 | 71 | 0.200 |
Why?
| | Cell Nucleolus | 1 | 2021 | 17 | 0.200 |
Why?
| | Middle Aged | 7 | 2021 | 26872 | 0.190 |
Why?
| | Carcinoma, Lobular | 1 | 2021 | 44 | 0.180 |
Why?
| | Carcinoma, Pancreatic Ductal | 1 | 2023 | 208 | 0.180 |
Why?
| | Cytodiagnosis | 1 | 2020 | 29 | 0.180 |
Why?
| | Radiosurgery | 1 | 2022 | 298 | 0.170 |
Why?
| | Papillomavirus Infections | 1 | 2022 | 258 | 0.170 |
Why?
| | Adenocarcinoma | 2 | 2023 | 795 | 0.160 |
Why?
| | Aged | 5 | 2021 | 19135 | 0.160 |
Why?
| | Urinary Tract Infections | 1 | 2020 | 134 | 0.160 |
Why?
| | Receptors, Estrogen | 1 | 2021 | 372 | 0.160 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2021 | 371 | 0.150 |
Why?
| | Head and Neck Neoplasms | 1 | 2022 | 427 | 0.150 |
Why?
| | Cholangiopancreatography, Endoscopic Retrograde | 1 | 2020 | 182 | 0.150 |
Why?
| | Pseudomonas aeruginosa | 1 | 2020 | 299 | 0.150 |
Why?
| | Carcinoma, Medullary | 1 | 2017 | 13 | 0.150 |
Why?
| | Cytological Techniques | 1 | 2017 | 23 | 0.150 |
Why?
| | Cell Cycle Proteins | 1 | 2021 | 551 | 0.140 |
Why?
| | Cholestasis | 1 | 2020 | 225 | 0.140 |
Why?
| | Observer Variation | 1 | 2017 | 298 | 0.140 |
Why?
| | Histocytochemistry | 1 | 2015 | 78 | 0.130 |
Why?
| | S100 Proteins | 1 | 2015 | 38 | 0.120 |
Why?
| | Antigens, Differentiation, Myelomonocytic | 1 | 2015 | 53 | 0.120 |
Why?
| | Female | 7 | 2021 | 59717 | 0.120 |
Why?
| | Pancreas | 1 | 2017 | 280 | 0.120 |
Why?
| | Gene Rearrangement | 1 | 2015 | 136 | 0.120 |
Why?
| | Humans | 11 | 2023 | 115219 | 0.120 |
Why?
| | Receptor Protein-Tyrosine Kinases | 1 | 2015 | 226 | 0.110 |
Why?
| | Kidney | 1 | 2020 | 1188 | 0.110 |
Why?
| | Receptors, Cell Surface | 1 | 2015 | 356 | 0.110 |
Why?
| | Antigens, CD | 1 | 2015 | 441 | 0.100 |
Why?
| | Lymph Nodes | 1 | 2015 | 422 | 0.100 |
Why?
| | Pyrazoles | 1 | 2015 | 361 | 0.100 |
Why?
| | Male | 6 | 2021 | 55811 | 0.100 |
Why?
| | Pyridines | 1 | 2015 | 424 | 0.100 |
Why?
| | Retrospective Studies | 3 | 2023 | 12596 | 0.090 |
Why?
| | Anti-Bacterial Agents | 1 | 2020 | 1481 | 0.090 |
Why?
| | Neoadjuvant Therapy | 2 | 2023 | 298 | 0.090 |
Why?
| | B-Lymphocytes | 1 | 2015 | 772 | 0.090 |
Why?
| | Breast Neoplasms | 1 | 2021 | 1865 | 0.090 |
Why?
| | Magnetic Resonance Imaging | 1 | 2020 | 3128 | 0.080 |
Why?
| | Brain Neoplasms | 1 | 2015 | 984 | 0.070 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 1 | 2015 | 962 | 0.070 |
Why?
| | Adult | 4 | 2021 | 30708 | 0.070 |
Why?
| | Young Adult | 1 | 2021 | 10519 | 0.070 |
Why?
| | CA-19-9 Antigen | 1 | 2023 | 13 | 0.050 |
Why?
| | Lung Neoplasms | 1 | 2015 | 2200 | 0.050 |
Why?
| | Lung | 1 | 2015 | 3595 | 0.050 |
Why?
| | MCF-7 Cells | 1 | 2021 | 105 | 0.050 |
Why?
| | Breast | 1 | 2021 | 139 | 0.050 |
Why?
| | Tamoxifen | 1 | 2021 | 192 | 0.040 |
Why?
| | Bile Duct Neoplasms | 1 | 2020 | 56 | 0.040 |
Why?
| | Constriction, Pathologic | 1 | 2020 | 210 | 0.040 |
Why?
| | Microscopy, Confocal | 1 | 2020 | 305 | 0.040 |
Why?
| | Promoter Regions, Genetic | 1 | 2021 | 1133 | 0.030 |
Why?
| | Transcriptome | 1 | 2021 | 725 | 0.030 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2023 | 1354 | 0.030 |
Why?
| | Cell Line, Tumor | 1 | 2021 | 2715 | 0.030 |
Why?
| | Cell Proliferation | 1 | 2021 | 2192 | 0.030 |
Why?
| | Inflammation | 1 | 2023 | 2485 | 0.030 |
Why?
| | Treatment Outcome | 1 | 2023 | 9151 | 0.020 |
Why?
| | Signal Transduction | 1 | 2021 | 4527 | 0.020 |
Why?
| | Prognosis | 1 | 2015 | 3336 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2017 | 6358 | 0.020 |
Why?
| | Prospective Studies | 1 | 2017 | 6245 | 0.020 |
Why?
|
|
Mehrotra's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|